Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Sparacino

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2006
Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case reportVito Sparacino, Sergio Calabrese
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 3, 2019
[Editorial]Massimo Cardillo, Letizia Lombardini, Vito Sparacino, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 5, 2016
[Italian Registry Dialysis and Transplant 2011-2013]Maurizio Nordio, Aurelio Limido, Ferruccio Conte, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 14, 2005
Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effectsRaimund Margreiter, Erich Pohanka, Vito Sparacino, et al.
Archives of Medical Research|June 15, 2007
Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive proteinFrancesco Vaccaro, Giuseppe Mulè, Santina Cottone, et al.
Journal of the American Society of Nephrology : JASN|April 27, 2007
Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trialGiuseppe Remuzzi, Paolo Cravedi, Marco Costantini, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Performance of different prediction equations for estimating renal function in kidney transplantationFlavio Gaspari, Silvia Ferrari, Nadia Stucchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 26, 2007
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidanceJosep M Campistol, Joan Albanell, Wolfgang Arns, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009Pierluca Piselli, Diego Serraino, Giuseppe Paolo Segoloni, et al.
Lancet (London, England)|August 11, 2004
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trialGiuseppe Remuzzi, Mariadomenica Lesti, Eliana Gotti, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2006
Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case reportVito Sparacino, Sergio Calabrese
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 3, 2019
[Editorial]Massimo Cardillo, Letizia Lombardini, Vito Sparacino, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 5, 2016
[Italian Registry Dialysis and Transplant 2011-2013]Maurizio Nordio, Aurelio Limido, Ferruccio Conte, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 14, 2005
Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effectsRaimund Margreiter, Erich Pohanka, Vito Sparacino, et al.
Archives of Medical Research|June 15, 2007
Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive proteinFrancesco Vaccaro, Giuseppe Mulè, Santina Cottone, et al.
Journal of the American Society of Nephrology : JASN|April 27, 2007
Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trialGiuseppe Remuzzi, Paolo Cravedi, Marco Costantini, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Performance of different prediction equations for estimating renal function in kidney transplantationFlavio Gaspari, Silvia Ferrari, Nadia Stucchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 26, 2007
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidanceJosep M Campistol, Joan Albanell, Wolfgang Arns, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009Pierluca Piselli, Diego Serraino, Giuseppe Paolo Segoloni, et al.
Lancet (London, England)|August 11, 2004
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trialGiuseppe Remuzzi, Mariadomenica Lesti, Eliana Gotti, et al.
Pageof 2